The typical contrast is between a highly cellular, relatively scantily supported encephaloid cancer and a fibroplastic growth composed predominantly of elongated cells and developing fibrous material. Neither historical name is a complete modern tumour classification.
In encephaloid cancer, a thin preparation from a viable region shows crowded, variably sized cells, often rounded, oval, polygonal or irregular, with conspicuous cell nuclei and a prominent cell nucleolus. Some cells have more than one cell nucleus; the cytoplasm and nuclear proportions vary. In sections, the cells form masses or groups separated by a comparatively delicate vascular stroma. Where the lesion is a carcinoma, cohesive epithelial arrangements and invasion of surrounding tissue help establish its nature. The scant support helps explain the soft, brain-like gross consistency denoted by “encephaloid”; it does not mean that the growth is made of brain tissue.
A rapidly growing soft tumour may also show evidence of mitosis, haemorrhage, necrosis and granular or fatty cellular debris. These features vary with sampling and are not the definition of every historical encephaloid lesion. The viable advancing edge is more informative about cell type and invasion than a completely broken-down centre. A modern interpretation combines architecture, cell morphology and, where needed, immunohistochemistry; one large nucleolated cell is not a universal “cancer corpuscle.”[ref][ref]
In a typical fibroplastic growth, the conspicuous elements are oval or spindle-shaped cells, with elongated cell nuclei, tapering processes and intercellular material taking on a fibrillar character. The cells may run in parallel bundles or interlacing groups. Some areas contain many apparently free oval cell nuclei; other areas show more mature fibres and fewer obvious cell bodies. A teased preparation helps display individual elongated cells and fibres, whereas a section shows how the bundles relate to vessels and surrounding tissue.
The historical interpretation was of a growth resembling developing connective tissue. It should not be translated automatically into either a harmless fibroma or a specific modern fibrosarcoma. Contemporary descriptions recorded recurrence and malignant behaviour in some growths put in this broad category.[ref] Cell shape must be read with tissue architecture and behaviour. Apparent resemblance to fibroblasts does not establish benignity, and a scant-fibred soft growth is not by itself proof of epithelial origin.
An historically appropriate classification distinguishes the hard, soft, gelatinous, pigmented and epithelial malignant growths, together with recurrent and destructive growths whose place in “cancer” was disputed. Modern classification instead distinguishes tumours by cellular lineage and biological behaviour.
The quotation marks around “Malignant” matter. In 1867 the clinical grouping did not have a single settled boundary in histology. Infiltration, destructive growth, return after removal, spread to distant sites and progressive constitutional illness were warning features; hardness or rapid growth alone was not a sufficient definition. A contemporary review of an 1866 textbook explicitly disputed confused descriptions of hard and soft cancer, illustrating that this was already a live diagnostic controversy.[ref]
A useful period classification, without pretending that every contemporary author drew the same boundaries, is:
Those are overlapping historical descriptive groups, not six mutually exclusive modern diagnoses. Nor does every growth historically called “sarcoma” meet the modern definition of sarcoma.
The modern organising principle asks what cells are malignant. Carcinoma arises from epithelium; sarcoma arises in bone or soft tissue; melanoma arises from melanocytes; lymphoma and leukaemia concern blood-forming or immune cells. Other families include central nervous system and germ cell tumours. A solid lump is not essential for cancer. Within a family, histology, immunohistochemistry and appropriate molecular diagnostics refine the diagnosis. Tumour grade describes features of aggressiveness, whereas tumour stage describes extent of disease.[ref]
This also corrects the old inference that recurrence must reflect a mysterious constitutional deposit: local residual disease and metastasis are distinct mechanisms, and an apparently circumscribed growth may already have disseminated.